The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection
Authors:
- Donald P. KotlerDKDonald P. Kotler
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 25 (3) , 469-478
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral TherapyDiabetes Care, 2010
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) StudyThe Journal of Infectious Diseases, 2010
- Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency VirusCirculation, 2009
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected PatientsDiabetes Care, 2008
- Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV–HCV–coinfected patients under highly active antiretroviral treatmentEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Regulation of Plasma PAI-1 Concentrations in HAART-Associated Lipodystrophy During Rosiglitazone TherapyArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus InfectionMayo Clinic Proceedings, 2000
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994